Back
SpringWorks Therapeutics Quote, Financials, Valuation and Earnings
Buy
64
SWTX
SpringWorks Therapeutics
Last Price:
44.86
Seasonality Move:
0.17%
7 Day Trial
ALL ACCESS PASS
$
7
SpringWorks Therapeutics Price Quote
$44.86
+0.02 (+0.2%)
(Updated: May 18, 2024 at 5:54 AM ET)
SpringWorks Therapeutics Key Stats
Buy
64
SpringWorks Therapeutics (SWTX)
is a Buy
Day range:
$43.80 - $44.95
52-week range:
$18.00 - $53.92
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
5.85%
Volume:
693.3K
Avg. volume:
854.6K
1-year change:
59.12%
Market cap:
$3.3B
Revenue:
$5.4M
EPS:
$-5.15
How Much Does SpringWorks Therapeutics Make?
Data Unavailable
Is SpringWorks Therapeutics Growing As A Company?
Data Unavailable
SpringWorks Therapeutics Stock Price Performance
-
Did SpringWorks Therapeutics Stock Go Up Last Month?
SpringWorks Therapeutics share price went up by 1.66% last month -
Did SWTX's Share Price Rise Over The Last Year?
SWTX share price rose by 59.12% over the past 1 year
What Is SpringWorks Therapeutics 52-Week High & Low?
-
What Is SpringWorks Therapeutics’s 52-Week High Share Price?
SpringWorks Therapeutics has traded as high as $53.92 over the past 52 weeks -
What Is SpringWorks Therapeutics’s 52-Week Low Share Price?
SpringWorks Therapeutics has traded as low as $18.00 over the past 52 weeks
SpringWorks Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy SpringWorks Therapeutics?
-
How Much Debt Does SpringWorks Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does SpringWorks Therapeutics Have?
Cash and short term investments quarterly total is $436.6M -
What Is SpringWorks Therapeutics’s Book Value Per Share?
Book value per share is 7.66
Is SpringWorks Therapeutics Cash Flow Positive?
-
What Is SWTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$239.9M -
What Is SpringWorks Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $297.9M -
What Is SpringWorks Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$42.4M
SpringWorks Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
SWTX return on invested capital is -66.56% -
What Is SpringWorks Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -57.73% -
What Is SWTX Return On Equity?
ROE is a measure of profitability and is -66.56%
SpringWorks Therapeutics Earnings Date & Stock Price
-
What Is SpringWorks Therapeutics's Stock Price Today?
A single share of SWTX can be purchased today for 44.84 -
What Is SpringWorks Therapeutics’s Stock Symbol?
SpringWorks Therapeutics trades on the nasdaq under the ticker symbol: SWTX -
When Is SpringWorks Therapeutics’s Next Earnings Date?
The next quarterly earnings date for SpringWorks Therapeutics is scheduled on August 2, 2024 -
When Is SWTX's next ex-dividend date?
SpringWorks Therapeutics's next ex-dividend date is May 19, 2024 -
How To Buy SpringWorks Therapeutics Stock?
You can buy SpringWorks Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
SpringWorks Therapeutics Competitors
-
Who Are SpringWorks Therapeutics's Competitors?
Below is a list of companies who compete with SpringWorks Therapeutics or are related in some way:
SpringWorks Therapeutics Dividend Yield
Data Unavailable
SpringWorks Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -11.5% |
| Revenue: | 0% | 60.74% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 67.36 |
| Upside from Last Price: | 50.23% |